ASK REDCHAT ANYTHING ABOUT BIOCRYST PHARMACEUTICALS INC.
BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX)
Listen to this Section
$9.38
+0.2700
(
+2.96% )
1.1M
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Orladeyo (Berotralstat)DetailsRare diseases, Rare genetic disease, Hereditary angioedema |
Approved |
| Rapivab (Peramivir)DetailsInfluenza, Acute lymphoblastic leukemia, Leukemia |
Approved |
| BCX17725 (KLK5 Inhibitor)DetailsNetherton syndrome |
Phase 1 |
| BCX10013DetailsComplement mediated diseases, Paroxysmal nocturnal hemoglobinuria |
Failed |
| Galidesivir (BCX4430)DetailsCOVID-19 |
Failed |
| BCX9930DetailsParoxysmal nocturnal hemoglobinuria |
Failed |
| BCX9250DetailsFibrodysplasia ossificans progressiva |
Failed |
| BCX17725DetailsNetherton syndrome |
Phase 1 |
Market Data
|
| Open |
$9.38 |
| Previous Close |
$9.11 |
| Volume |
1.1M |
| Market Cap |
$2.32B |
| Day Range |
$9.10 - $9.39 |
| 52 Week Range |
$6.00 - $11.22 |
| Shares Outstanding |
254.16M |
| Change % |
+2.96% |
| Net Change |
▲ 0.2700 |
| Insider Ownership |
-0.09% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Year | 1994 |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
-263,440.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-06-25 |
Sale |
-8600.00 |
McKee Amy E |
| 2024-06-17 |
Sale |
-4689.00 |
SANDERS MACHELLE |
| 2024-06-14 |
Sale |
-6820.00 |
Galson Steven K |
| 2024-06-14 |
Sale |
-6820.00 |
ABERCROMBIE GEORGE B |
| 2024-06-14 |
Sale |
-6820.00 |
MILANO VINCENT |
| 2024-06-14 |
Sale |
-6820.00 |
SANDERS MACHELLE |
| 2024-06-14 |
Sale |
-6820.00 |
HEGGIE THERESA |
| 2024-06-14 |
Sale |
-6820.00 |
LEVIN ALAN G |
| 2024-06-14 |
Sale |
-6820.00 |
McKee Amy E |
| 2024-06-14 |
Sale |
-6820.00 |
ASELAGE STEVE |